Screener
Canopy Growth Corporation CGC Business Segments
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| Revenue (Gross) by Product | ||||||
| Canadian Adult Use Cannabis | $29.7M+9.9% | $20.58M+0.9% | $22.93M+8.4% | $23.94M+30.2% | $27.02M+43.1% | |
| Canadian Medical Cannabis | $25.79M+21.6% | $25.28M+26.6% | $22.51M+15.0% | $21.82M+16.8% | $21.21M+12.8% | |
| Storz Bickel | $16.08M+6.1% | $16.78M-14.0% | $22.89M-8.6% | $15.83M-9.9% | $15.15M-24.7% | |
| Revenue by Geography | ||||||
| CA | $54.94M+13.9% | $46.67M+15.4% | $45.44M+11.6% | $45.76M+23.4% | $48.23M+28.0% | |
| DE | $17.59M+22.3% | $15.77M+26.7% | $19.2M+8.2% | $12.73M-10.4% | $14.38M-7.3% | |
| US | $6.23M+4.3% | $7.25M-14.4% | $8.67M-25.0% | $6.37M-13.2% | $5.97M-30.7% |
FAQ
- How does Canopy Growth Corporation break its business down?
- Canopy Growth Corporation (CGC) reports revenue (gross) by product across 3 parts — Canadian Adult Use Cannabis, Canadian Medical Cannabis and Storz Bickel. Each is extracted from the segment footnotes and tracked over time.
- Where does Canopy Growth Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Canopy Growth Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
